Panel on the next generation of corporate venturing leaders, moderated by Neil Foster from Baker Botts.
Category: People
Symposium 2012: David Lawson, P&G
Keynote presentation by David Lawson, open innovation manager at Procter and Gamble.
Symposium 2012: Healthcare Q&A
Edited highlights from last month’s Keynote Healthcare Q&A at the Global Corporate Venturing Symposium 2012 with Merck’s William Taranto and Cleveland Clinic’s Tom Thornton.
Fortune joins Cleveland Clinic Innovations
Venture firm Boston Millennia Partners’s Patrick Fortune joins Cleveland Clinic Innovations.
Kevin Rose joins Google Ventures
Entrepreneur Kevin Rose follows up exit of Milk to Google by joining Google Ventures.
Intel Capital makes Aksoy Turkey head
Intel’s corporate venturing unit opens a Turkey office after backing digital media company Nokta and daily deals company Grupanya.
Socolof becomes NVCA corporate chair
Socolof says: “I am honored to represent this growing constituency within our industry as the landscape continues to evolve.”
Inerjys hires Shah, Pullan
The clean technology investment firm and utility recruits Carbon War Room’s Jigar Shah and Nomura’s Russell Pullan.
Quinn joins KPCB from Square
Quinn previously was head of products for Visa-backed mobile payment company Square, a KPCB portfolio company.
Sallner adds his data to SkySQL
Ulf Sandberg, the incumbent CEO of Finland-based SkySQL, will now serve as president, leading the company’s operations in the Americas.
Cheiky steps up to chair Cool Planet
Howard Janzen has joined as executive president from being chief executive at One Communications, where he oversaw the integration of eight regional communications companies.
Feldman joins CrunchFund
He previously was a senior director of special projects at internet services provider AOL, which acquired TechCrunch, a media group that started the corporate venturing fund, and, before that, was director of user experience at Yahoo.
Gonnissen reemerges at QBIC
Gonnissen had spent two and a half years as manager of corporate venturing at Bekaert before leaving last month for a university venturing fund.
Lundemose joins PolyTherics’ board
Lundemose is co-founder of several companies including Symphogen, Santaris and Prosidion, a UK subsidiary of OSI Pharmaceuticals where he had been a managing director of OSI’s corporate venturing unit.